Painkiller sale plan to US gives France major headache

The planned sale of France’s best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides.

Source

(Except for the headline, this story has not been edited by PostX News and is published from a syndicated feed.)